Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Organogenesis Holdings Inc. specializes in regenerative medicine and tissue-based products for advanced wound care, surgical, and sports medicine markets. Its core offerings include skin substitutes, placental allografts, and collagen biomaterials designed to promote healing of chronic and acute wounds. Serving hospitals, clinics, and surgical centers, the company leverages proprietary technologies, FDA-approved biologics, and a broad product pipeline to address growing healthcare needs driven by aging populations and chronic diseases.
This description was generated via AI from an annual report. Updated about 1 year ago.